According to the report, the following are the summaries of 5 major venture capitalists involved in biotech.
1. Arch Venture Partners
– Founded in 1986
– The company has roughly $9 billion under management as of 2022
– The firm has backed big names such as Juno Therapeutics, Neumora Therapeutics, and Illumina.
– Recently led rounds including a $60 million Series A closed by Gate Bioscience.
1. Flagship Pioneering
– Founded in 1999
– It raised $3.4 billion in 2021, raising Flagship’s assets under management to $14.1 billion.
– Set up the famed mRNA developer Moderna.
– Its recent investments are $140 million Series B round closed by Harbinger Health and a $273 million Series C round bagged by Generate Biomedicines.
1. OrbiMed
– Established as a money-management and research firm in 1989
– One of the biggest healthcare-focused investment firms in the world, with more than $17 billion in assets under management
– Portfolio companies are liquid biopsy developer Guardant Health, and cell-free DNA testing company Natera.
1. RA Capital Management
– Founded in 2002
– $10 billion in assets under management
– One of RA Capital’s portfolio successes is the Flagship Pioneering-founded Moderna.
– Recently participated in a $105 million Series C round raised by Alentis Therapeutics and an $85 million Series A round for Rampart Bioscience.
1. Versant Ventures
– Established in 1999
– Manages approximately $4.2 billion in assets
– Recently joined Arch in backing Gate Bioscience’s Series A round.
The life sciences champions: Top 5 mighty venture capital movers!
Latest from Blog
Arch Venture Partners secures over $3bn for Fund XIII
TLDR: Arch Venture Partners has raised over $3 billion for Fund XIII. Investors in the fund include Alaska Permanent Fund and Rockefeller Brothers Fund. In a recent development, Arch Venture Partners has
Raising Your First Venture Fund: Tips for Success
TLDR: Samir Kaji, a seasoned venture capital professional, shares a six-point plan for raising a venture fund as a first-time fund manager. Key steps include staying focused on a niche, not worrying
Exploring China’s Quantum Computing Breakthrough and VC Trends
TLDR: ONCO stock surged over 80% in pre-market after Altos Venture acquired a stake Chinese low float stocks like DUO rose over 40% in sympathy with large caps Summary: The article discusses
The Blindspot: Venture Capitalists’ Go-To Tool with Fatal Flaw
TLDR: Nader Al-Naji, founder of Bitclout, was arrested for an alleged crypto scam involving VC giant Andreessen Horowitz as a victim. VCs’ pattern matching led them to invest in Al-Naji despite red
Korean startups seek corporate investors in challenging ecosystem climate
TLDR: Korean startups are seeking corporate investors as funding becomes harder to secure. The government in South Korea has relaxed CVC rules to attract more foreign investment. Korean startups are facing a